Skip to main content
. 2017 Jan 5;7(1):e013927. doi: 10.1136/bmjopen-2016-013927

FigureĀ 5.

FigureĀ 5

Separate and pooled relative risk and 95% CIs estimates for safety outcomes among all included trials (pioglitazone vs control).

OSZAR »